Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001005477-04-003882
Filing Date
2004-11-02
Accepted
2004-11-02 16:58:50
Documents
2
Period of Report
2004-10-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 edgar123.html 4  
1 FORM 4 edgar123.xml 4 7632
2 exh99.txt EX-99 1087
  Complete submission text file 0001005477-04-003882.txt   11713
Mailing Address
Business Address 1124 COLUMBIA STREET SUITE 130 SEATTLE WA 98104 2062626200
XCYTE THERAPIES INC (Issuer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ARCH VENTURE CORP 8725 W. HIGGINS RD #290 CHICAGO IL 60631
Business Address C/O ARCH VENTURE PARTNERS 8725 W. HIGGINS RD #290 CHICAGO IL 60631 7733806600
ARCH MANAGEMENT PARTNERS II LP (Reporting) CIK: 0001274393 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50626 | Film No.: 041113969

Mailing Address C/O ARCH VENTURE PARTNERS LP 8725 W. HIGGINS RD. #290 CHICAGO IL 60631
Business Address C/O ARCH VENTURE PARTNERS 8725 W. HIGGINS RD #290 CHICAGO IL 60631 7733806600
ARCH VENTURE PARTNERS LP (Reporting) CIK: 0001274396 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50626 | Film No.: 041113968

Mailing Address C/O ARCH VENTURE PARTNERS 8725 W. HIGGINS RD. #290 CHICAGO IL 60631
Business Address C/O ARCH VENTURE PARTNERS 8725 W. HIGGINS RD #290 CHICAGO IL 60631 7733806600
ARCH VENTURE CORP (Reporting) CIK: 0001274403 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50626 | Film No.: 041113967